Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Orthopedics/Orthopedic Surgery
Disease Category: Ankylosing Spondylitis
Location: United States, GA

Clinical Trial Details

Overview

Research Study Summary

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Purpose

24-Week trial comparing treatment with Study Medicine vs. placebo.

Patient Inclusion Criteria:

  • Age >/= 18
  • Diagnosis of definite AS
  • Active AS
  • Inadequate response to treatment.

Patient Exclusion Criteria:

  • Major Surgery within 8 weeks prior to screening
  • Inflammatory Disease other than AS
  • Treatment with Investigational Medication within 4 weeks
  • Hepatitis B, C, or HIV

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Duration

24 Weeks

Facility Type

N/A

Contact

Suzi DeFiesta, Research Administrator
CSI Research Inc
11379 Southbridge Parkway, Suite B
Alpharetta, GA 30022
Phone: 770-667-0220
Fax: 770-667-0227

View Map

Research Center Information: CSI Research Inc

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 165441

Date Last Changed: July 23, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.